DAE HWA Pharmaceutical Co. Ltd (067080) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.004x

Based on the latest financial reports, DAE HWA Pharmaceutical Co. Ltd (067080) has a cash flow conversion efficiency ratio of 0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩314.63 Million ≈ $213.22K USD) by net assets (₩85.06 Billion ≈ $57.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See DAE HWA Pharmaceutical Co. Ltd net asset quality index to measure how much of total assets are equity-financed.

DAE HWA Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how DAE HWA Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check DAE HWA Pharmaceutical Co. Ltd (067080) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

DAE HWA Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DAE HWA Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Winchester Bancorp, Inc. Common Stock NASDAQ:WSBK	0.013x
Complete Solaria, Inc. Common Stock NASDAQ:CSLR	1.474x
Intema Insaat ve Tesisat Malzemeleri Yatirim ve Pazarlama AS IS:INTEM	-0.034x
Dohwa Engin KO:002150	-0.066x
Maiden Holdings Ltd NASDAQ:MHLD	-0.562x
CF Acquisition VII Corp NASDAQ:CFFS	N/A
CONDOR ENERGIES INC. F:WQ6	0.162x
Patria Bank SA RO:PBK	0.240x

Annual Cash Flow Conversion Efficiency for DAE HWA Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of DAE HWA Pharmaceutical Co. Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see DAE HWA Pharmaceutical Co. Ltd (067080) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩79.14 Billion ≈ $53.63 Million	₩5.43 Billion ≈ $3.68 Million	0.069x	-19.40%
2024-12-31	₩72.00 Billion ≈ $48.79 Million	₩6.13 Billion ≈ $4.15 Million	0.085x	+1155.66%
2023-12-31	₩73.23 Billion ≈ $49.63 Million	₩-590.27 Million ≈ $-400.02K	-0.008x	-107.81%
2022-12-31	₩77.99 Billion ≈ $52.85 Million	₩8.05 Billion ≈ $5.45 Million	0.103x	-21.32%
2021-12-31	₩79.67 Billion ≈ $53.99 Million	₩10.45 Billion ≈ $7.08 Million	0.131x	+270.58%
2020-12-31	₩81.98 Billion ≈ $55.56 Million	₩2.90 Billion ≈ $1.97 Million	0.035x	+6935.37%
2019-12-31	₩79.35 Billion ≈ $53.77 Million	₩-41.07 Million ≈ $-27.83K	-0.001x	-100.38%
2018-12-31	₩76.88 Billion ≈ $52.10 Million	₩10.49 Billion ≈ $7.11 Million	0.136x	-4.30%
2017-12-31	₩76.75 Billion ≈ $52.02 Million	₩10.94 Billion ≈ $7.42 Million	0.143x	+7.31%
2016-12-31	₩66.15 Billion ≈ $44.83 Million	₩8.79 Billion ≈ $5.96 Million	0.133x	+233.71%
2015-12-31	₩61.06 Billion ≈ $41.38 Million	₩2.43 Billion ≈ $1.65 Million	0.040x	-62.31%
2014-12-31	₩58.51 Billion ≈ $39.65 Million	₩6.18 Billion ≈ $4.19 Million	0.106x	-51.73%
2013-12-31	₩62.03 Billion ≈ $42.04 Million	₩13.57 Billion ≈ $9.20 Million	0.219x	+132.79%
2012-12-31	₩61.39 Billion ≈ $41.60 Million	₩5.77 Billion ≈ $3.91 Million	0.094x	+56.14%
2011-12-31	₩56.99 Billion ≈ $38.62 Million	₩3.43 Billion ≈ $2.32 Million	0.060x	--

About DAE HWA Pharmaceutical Co. Ltd

KQ:067080 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$114.64 Million

₩169.17 Billion KRW

Market Cap Rank

#18700 Global

#865 in Korea

Share Price

₩9450.00

Change (1 day)

-0.53%

52-Week Range

₩7870.00 - ₩23300.00

All Time High

₩45034.77